Article info

Download PDFPDF

5PSQ-071 Evaluation of the effectiveness and safety of vedolizumab for the treatment of inflammatory bowel disease
Free

Authors

Citation

Amor M, Lobato-Matilla E, Giménez-Manzorro Á, et al
5PSQ-071 Evaluation of the effectiveness and safety of vedolizumab for the treatment of inflammatory bowel disease

Publication history

  • First published March 11, 2019.
Online issue publication 
May 12, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.